Stoke Therapeutics, Inc. · NASDAQ:STOK
Cowen Financial Products LLC reported a 5.80% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
Cowen Financial Products LLC reported a 5.80% stake in Stoke Therapeutics, Inc., 3,173,258 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 3,173,258
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cowen Financial Products LLC | 5.80% | 3,173,258 |
Source
Related
- Stoke Therapeutics, Inc.
- Cowen Financial Products LLC
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · Cowen Financial Products LLC · Nov 14, 2025
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026